Peiqi Zhao

9PUBLICATIONS
16CO-AUTHORS
Respiratory diseasesInnate immunityCancer therapy (excl. chemotherapy and radiation therapy)NanophotonicsMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Aug 13, 2026
Development and Validation of a Novel Geriatric Risk Score for Prognostication in Older Patients With Hodgkin Lymphoma: A Multicenter Retrospective Study.

|Feb 26, 2025
Enhanced Cancer Immunotherapy by Bacterial Cytoplasmic Membranes Coated Nanovaccines for Co-Delivery of Ovalbumin Antigen and Immune Adjuvants to Dendritic Cells in Lymph Nodes.

Peiqi Zhao, Yali Fan, Ziyou Wang

|Dec 06, 2024
Efficacy and Safety of Polatuzumab Vedotin Plus Rituximab, Cyclophosphamide, Doxorubicin and Prednisone for Previously Untreated Diffuse Large B-Cell Lymphoma: A Real-World, Multi-Center, Retrospective Cohort Study.

Peiqi Zhao, Shu Zhao, Chen Huang

|Oct 06, 2022
Upconversion Optogenetic Engineered Bacteria System for Time-Resolved Imaging Diagnosis and Light-Controlled Cancer Therapy.

Yingying Zhang, Xin Xue, Mingxi Fang

|Jan 14, 2022
Hybrid Membrane Nanovaccines Combined with Immune Checkpoint Blockade to Enhance Cancer Immunotherapy.

Peiqi Zhao, Yuanlin Xu, Wei Ji

|Jun 14, 2021
Biomimetic black phosphorus quantum dots-based photothermal therapy combined with anti-PD-L1 treatment inhibits recurrence and metastasis in triple-negative breast cancer.

Peiqi Zhao, Yuanlin Xu, Wei Ji

Pageof 2

Frequent Collaborators

2 joint publications

Yajun Li

1 joint publications

Yingying Zhang

1 joint publications

Jin Chang

1 joint publications

Hanjie Wang